Risk factors

Oceaneering International relies heavily on the cyclical offshore oil and gas industry, representing 58 percent of 2024 consolidated revenue from foreign operations.

PepGen has a history of operating losses with $271.5 million in accumulated deficits and no approved products. The company relies entirely on third parties for drug manufacturing and clinical trial execution. Drug candidates target rare genetic neuromuscular diseases via an unproven EDO platform.

Park National Corp operates under heavy regulatory scrutiny, managing credit risk across real estate portfolios in four states with assets approaching $10.0 billion. The bank faces operational vulnerabilities from third-party vendors, cybersecurity threats, and the constant pressure of adapting to rapid technological changes.

Public Storage faces high exposure to property tax hikes and climate risks in California. Google dependency for customer acquisition creates distinct marketing vulnerability. Development pipelines and debt costs are pressured by elevated interest rates.

Rivian faces substantial losses, needing capital raises and cost management as it scales EV production.

Rambus faces high customer and geographic revenue concentration, heavy reliance on third-party manufacturing, and intense competition in cyclical semiconductor markets.

Roper's risk profile is dominated by heavy reliance on acquisitions and massive goodwill totaling $19,312.9 million, alongside substantial indebtedness of $7,623.0 million.

Heavy reliance on PACCAR and Peterbilt for truck supply, parts, and inventory floor plan financing dominates operations. Substantial goodwill concentration in the truck segment exposes earnings to potential asset impairment risks. Dealership agreements are nonexclusive, short-term, and subject to termination upon ownership changes or violations.

Saia faces intense competition for qualified drivers, rising capital expenditures, and stringent environmental and safety regulations.

Summit relies entirely on ivonescimab, licensing it from Akeso with billions in potential milestone payments. Clinical trials, regulatory approvals, and manufacturing depend heavily on third-party contractors in China and elsewhere. The company has incurred significant operating losses and requires ongoing external capital to survive.

Tenable Holdings faces significant cybersecurity market competition, historical net losses, and geographical operational exposure in Israel and the United States.

Catastrophe, climate, reinsurance availability, and reinsurer collectability dominate exposure to property-and-casualty losses.